Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Allergy Immunotherapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Market Overview:

The global allergy immunotherapies market size reached US$ 2.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.0 Billion by 2028, exhibiting a growth rate (CAGR) of 9.8% during 2023-2028. 

Allergy immunotherapy, also known as desensitization or hypo-sensitization, is a preventive medical treatment for allergic reactions to allergens including various foods, drugs, bee venom, grass pollens and house dust mites. It alters the immune system’s response by gradually increasing the doses of the allergen. Before the treatment begins, an allergist and patient analyze triggering factors for allergy symptoms, which may involve skin and blood tests to confirm the allergens. Allergy immunotherapy helps in reducing inflammation, offering long-term impact, increasing immunological tolerance, changing the course of the disease and improving the quality of the patient’s life.

 

 
 

www.imarcgroup.com

Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

In recent years, there has been a rise in the prevalence of allergies around the world on account of various environmental and lifestyle factors that influence the functioning of the immune system. With the growing awareness of allergy immunotherapies, elevating income levels and increasing healthcare expenditure, the demand for sophisticated and long-term treatment options is increasing, which in turn is stimulating the growth of the market. It is further supported by the rising clinical research and development budget owing to several initiatives undertaken by both governmental and non-governmental organizations around the world. Further, with the latest drug development technologies, pharmaceutical firms have created more efficient immunotherapies for treating an array of allergies successfully. This, coupled with advancements in the field of allergy diagnostics, is catalyzing the global allergy immunotherapies market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global allergy immunotherapies market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on treatment type, allergy type and distribution channel.

Breakup by Treatment Type:

  • Subcutaneous Immunotherapy (SCIT)
  • Sublingual Immunotherapy (SLIT)
     

Breakup by Allergy Type:

  • Allergic Rhinitis
  • Asthma
  • Food Allergy
  • Venom Allergy
  • Others
     

Breakup by Distribution Channel:

 

 
 

www.imarcgroup.com

Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • Europe
  • North America
  • Asia Pacific
  • Middle East and Africa
  • Latin America
     

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being ALK-Abello A/S, Allergy Therapeutics, Stallergenes Greer, HAL Allergy Holding B.V., DBV Technologies, Merck KGaA, Aimmune Therapeutics, Circassia Pharmaceuticals, Anergis SA, and Biomay AG, etc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2022
Historical Period 2017-2022
Forecast Period 2023-2028
Units US$ Billion
Segment Coverage Treatment Type, Allergy Type, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Companies Covered ALK-Abello A/S, Allergy Therapeutics, Stallergenes Greer, HAL Allergy Holding B.V., DBV Technologies, Merck KGaA, Aimmune Therapeutics, Circassia Pharmaceuticals, Anergis SA, and Biomay AG
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Allergy Immunotherapies Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Breakup by Treatment Type
    5.5    Market Breakup by Allergy Type
    5.6    Market Breakup by Distribution Channel
    5.7    Market Breakup by Region
    5.8    Market Forecast
6   Market Breakup by Treatment Type
    6.1    Subcutaneous Immunotherapy (SCIT) 
        6.1.1    Market Trends
        6.1.2    Market Forecast
    6.2    Sublingual Immunotherapy (SLIT) 
        6.2.1    Market Trends
        6.2.2    Market Forecast
7   Market Breakup by Allergy Type
    7.1    Allergic Rhinitis
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    Asthma
        7.2.1    Market Trends
        7.2.2    Market Forecast
    7.3    Food Allergy
        7.3.1    Market Trends
        7.3.2    Market Forecast
    7.4    Venom Allergy
        7.4.1    Market Trends
        7.4.2    Market Forecast
    7.5    Others
        7.5.1    Market Trends
        7.5.2    Market Forecast
8   Market Breakup by Distribution Channel
    8.1    Hospital Pharmacy
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Retail Pharmacy 
        8.2.1    Market Trends
        8.2.2    Market Forecast
    8.3    Online Pharmacy
        8.3.1    Market Trends
        8.3.2    Market Forecast
9   Market Breakup by Region
    9.1    Europe
        9.1.1    Market Trends
        9.1.2    Market Forecast
    9.2    North America
        9.2.1    Market Trends
        9.2.2    Market Forecast
    9.3    Asia Pacific
        9.3.1    Market Trends
        9.3.2    Market Forecast
    9.4    Middle East and Africa
        9.4.1    Market Trends
        9.4.2    Market Forecast
    9.5    Latin America
        9.5.1    Market Trends
        9.5.2    Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
    13.1    Price Indicators
    13.2    Price Structure
    13.3    Margin Analysis
14  Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    ALK-Abello A/S
        14.3.2    Allergy Therapeutics
        14.3.3    Stallergenes Greer
        14.3.4    HAL Allergy Holding B.V.
        14.3.5    DBV Technologies
        14.3.6    Merck KGaA 
        14.3.7    Aimmune Therapeutics
        14.3.8    Circassia Pharmaceuticals 
        14.3.9    Anergis SA 
        14.3.10      Biomay AG 

List of Figures

Figure 1: Global: Allergy Immunotherapies Market: Major Drivers and Challenges
Figure 2: Global: Allergy Immunotherapies Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Allergy Immunotherapies Market: Breakup by Treatment Type (in %), 2022
Figure 4: Global: Allergy Immunotherapies Market: Breakup by Allergy Type (in %), 2022
Figure 5: Global: Allergy Immunotherapies Market: Breakup by Distribution Channel (in %), 2022
Figure 6: Global: Allergy Immunotherapies Market: Breakup by Region (in %), 2022
Figure 7: Global: Allergy Immunotherapies Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 8: Global: Allergy Immunotherapies Industry: SWOT Analysis
Figure 9: Global: Allergy Immunotherapies Industry: Value Chain Analysis
Figure 10: Global: Allergy Immunotherapies Industry: Porter’s Five Forces Analysis
Figure 11: Global: Allergy Immunotherapies (Subcutaneous Immunotherapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Allergy Immunotherapies (Subcutaneous Immunotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Allergy Immunotherapies (Sublingual Immunotherapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Allergy Immunotherapies (Sublingual Immunotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Allergy Immunotherapies (Allergic Rhinitis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Allergy Immunotherapies (Allergic Rhinitis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Allergy Immunotherapies (Asthma) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Allergy Immunotherapies (Asthma) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Allergy Immunotherapies (Food Allergy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Allergy Immunotherapies (Food Allergy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Allergy Immunotherapies (Venom Allergy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Allergy Immunotherapies (Venom Allergy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Allergy Immunotherapies (Other Allergy Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Allergy Immunotherapies (Other Allergy Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Allergy Immunotherapies Market: Sales through Hospital Pharmacy (in Million US$), 2017 & 2022
Figure 26: Global: Allergy Immunotherapies Market Forecast: Sales through Hospital Pharmacy (in Million US$), 2023-2028
Figure 27: Global: Allergy Immunotherapies Market: Sales through Retail Pharmacy (in Million US$), 2017 & 2022
Figure 28: Global: Allergy Immunotherapies Market Forecast: Sales through Retail Pharmacy (in Million US$), 2023-2028
Figure 29: Global: Allergy Immunotherapies Market: Online Sales (in Million US$), 2017 & 2022
Figure 30: Global: Allergy Immunotherapies Market Forecast: Online Sales (in Million US$), 2023-2028
Figure 31: Europe: Allergy Immunotherapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Europe: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: North America: Allergy Immunotherapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: North America: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Asia Pacific: Allergy Immunotherapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Asia Pacific: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Middle East and Africa: Allergy Immunotherapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Middle East and Africa: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Latin America: Allergy Immunotherapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Latin America: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2023-2028

List of Tables

Table 1: Global: Allergy Immunotherapies Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Allergy Immunotherapies Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
Table 3: Global: Allergy Immunotherapies Market Forecast: Breakup by Allergy Type (in Million US$), 2023-2028
Table 4: Global: Allergy Immunotherapies Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 5: Global: Allergy Immunotherapies Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Allergy Immunotherapies Market Structure
Table 7: Global: Allergy Immunotherapies Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global allergy immunotherapies market was valued at US$ 2.8 Billion in 2022.

We expect the global allergy immunotherapies market to exhibit a CAGR of 9.8% during 2023-2028.

The rising prevalence of several allergies based on environmental and lifestyle-based factors, along with
the growing consumer awareness towards numerous health benefits of allergy immunotherapies, is
currently driving the global allergy immunotherapies market.

The sudden outbreak of the COVID-19 pandemic has led to the rising adoption of allergy
immunotherapies in extensive R&D activities for analyzing the reaction of novel COVID-19 vaccines,
thereby augmenting the market growth.

Based on the treatment type, the global allergy immunotherapies market can be bifurcated into
subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT), where subcutaneous
immunotherapy (SCIT) holds the majority of the total market share.

Based on the allergy type, the global allergy immunotherapies market has been segregated into allergic
rhinitis, asthma, food allergy, venom allergy, and others. Currently, allergic rhinitis represents the largest market share.

Based on the distribution channel, the global allergy immunotherapies market can be divided into
hospital pharmacy, retail pharmacy, and online pharmacy. Among these, hospital pharmacy accounts for
the majority of the total market share.

On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin
America, and Middle East and Africa, where Europe currently dominates the global market.

Some of the major players in the global allergy immunotherapies market include ALK-Abello A/S, Allergy Therapeutics, Stallergenes Greer, HAL Allergy Holding B.V., DBV Technologies, Merck KGaA, Aimmune Therapeutics, Circassia Pharmaceuticals, Anergis SA, Biomay AG, etc.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4